This fully funded tuition fee waiver programme is awarded by the Universities of Glasgow, Aberdeen and Strathclyde, and in collaboration with the Universities of Dundee and Edinburgh. Students can be based in either Glasgow or Aberdeen, and should indicate the preferred campus in their application.
Precision medicine and pharmacological innovation holds huge potential in the timely development of new treatments for human disease. It is among the most important concepts to emerge in 21st century clinical science and will be a crucial component of the global drive to increase the efficacy, safety and cost effectiveness of new treatments. This new taught postgraduate Masters programme draws on the current and future needs of the Life Sciences sector, to create a highly skilled workforce and is being developed in conjunction with the industrial partners of the Stratified Medicine Scotland Innovation Centre (SMS-IC). It harnesses Scotland’s strengths in stratified medicine, clinical trials, bioinformatics and pharmacogenomics to provide focused training which integrates basic and clinical sciences, and equips students with grounding in the essential skills required to design, execute and evaluate modern clinical interventions.
Candidates must normally possess:
Please see our website for fee information
Graduates will be able to pursue careers in a variety of academic and industrial areas including clinical research, preclinical lab-based research, business development with expert knowledge in life sciences and bioinformatics/biostatistics.
Many graduates from this programme have gone on to work in global companies as well as SMEs working in life sciences research.
Example job titles include:
A number of graduates have gone on to graduate entry to Medicine programmes and into PhDs in Medicine, Biotechnology, Immunology and Precision Medicine.
A history of securing bright futuresThe University of Glasgow established in 1451 is the fourth-oldest university in the English-speaking world, and r...